
© 2025 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
14,635 | 14,975 | 13:23 | |
14,615 | 14,800 | 12:33 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
08:16 | TELIX PHARMACEUTICALS LIMITED: Change in substantial holding | ||
Di | Telix beginnt Studie für neue Weichteilsarkom-Therapie | ||
Di | Telix begins trial for new soft tissue sarcoma therapy | ||
Di | Telix Pharmaceuticals Limited: Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma | MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase... ► Artikel lesen | |
Mo | TELIX PHARMACEUTICALS LIMITED: Pending Release of Shares from Voluntary Escrow |
Unternehmen / Aktien | Kurs | % |
---|---|---|
TELIX PHARMACEUTICALS LIMITED | 14,650 | -3,04 % |